Reduction of permanent pacemaker implantation by using the cusp overlap technique in transcatheter aortic valve replacement: a meta-analysis.
Conduction disturbance
Cusp overlap projection
Pacemaker
TAVR
Transcatheter aortic valve replacement
Journal
Clinical research in cardiology : official journal of the German Cardiac Society
ISSN: 1861-0692
Titre abrégé: Clin Res Cardiol
Pays: Germany
ID NLM: 101264123
Informations de publication
Date de publication:
May 2023
May 2023
Historique:
received:
05
10
2022
accepted:
23
12
2022
medline:
8
5
2023
pubmed:
20
1
2023
entrez:
19
1
2023
Statut:
ppublish
Résumé
The need for permanent pacemaker (PPM) implantation is a common complication after transcatheter aortic valve replacement (TAVR). Deep implantation position is a risk factor for PPM implantation. Thus, in the field of self-expandable (SE) transcatheter heart valves (THV) cusp overlap projection (COP) technique was implemented to reduce parallax, allowing a more precise guidance of implantation depth. This meta-analysis aims to report the outcome of patients undergoing TAVR with SE THV using COP versus conventional implantation technique (CIT). Systematical search in MEDLINE and EMBASE yielded five observational controlled studies comparing both implantation techniques for the SE Evolut prosthesis (Medtronic Intern. Ltd., CA, USA) and fulfilling the inclusion criteria for meta-analysis. Totally, 1227 patients were included, comprising 641 who underwent COP and 586 CIT TAVR. Incidence of post-procedural need for PPM implantation was significantly lower in COP group (9.8% vs 20.6%; OR = 0.43; p < 0.00001). This was accompanied by significantly higher implantation position in COP group (mean difference distance from distal end of the intraventricular portion of the THV to the non-coronary cusp (NCC): - 1.03 mm; p = 0.00001). Incidence of new-onset left bundle branch block did not differ. Regarding procedural and 30-day mortality, technical success, post-procedural aortic regurgitation, and rates of multiple device implantation, no difference between COP and CIT was found. COP is an effective and safe implantation technique to reduce the need for a permanent pacemaker implantation during TAVR with SE Evolut prosthesis.
Sections du résumé
BACKGROUND
BACKGROUND
The need for permanent pacemaker (PPM) implantation is a common complication after transcatheter aortic valve replacement (TAVR). Deep implantation position is a risk factor for PPM implantation. Thus, in the field of self-expandable (SE) transcatheter heart valves (THV) cusp overlap projection (COP) technique was implemented to reduce parallax, allowing a more precise guidance of implantation depth.
AIMS
OBJECTIVE
This meta-analysis aims to report the outcome of patients undergoing TAVR with SE THV using COP versus conventional implantation technique (CIT).
METHODS
METHODS
Systematical search in MEDLINE and EMBASE yielded five observational controlled studies comparing both implantation techniques for the SE Evolut prosthesis (Medtronic Intern. Ltd., CA, USA) and fulfilling the inclusion criteria for meta-analysis.
RESULTS
RESULTS
Totally, 1227 patients were included, comprising 641 who underwent COP and 586 CIT TAVR. Incidence of post-procedural need for PPM implantation was significantly lower in COP group (9.8% vs 20.6%; OR = 0.43; p < 0.00001). This was accompanied by significantly higher implantation position in COP group (mean difference distance from distal end of the intraventricular portion of the THV to the non-coronary cusp (NCC): - 1.03 mm; p = 0.00001). Incidence of new-onset left bundle branch block did not differ. Regarding procedural and 30-day mortality, technical success, post-procedural aortic regurgitation, and rates of multiple device implantation, no difference between COP and CIT was found.
CONCLUSION
CONCLUSIONS
COP is an effective and safe implantation technique to reduce the need for a permanent pacemaker implantation during TAVR with SE Evolut prosthesis.
Identifiants
pubmed: 36656375
doi: 10.1007/s00392-022-02150-8
pii: 10.1007/s00392-022-02150-8
pmc: PMC10160159
doi:
Types de publication
Meta-Analysis
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
633-644Informations de copyright
© 2023. The Author(s).
Références
Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, Capodanno D, Conradi L, De Bonis M, De Paulis R, Delgado V, Freemantle N, Gilard M, Haugaa KH, Jeppsson A, Jüni P, Pierard L, Prendergast BD, Sádaba JR, Tribouilloy C, Wojakowski W, E.E.S.D. Group (2022) 2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 43(7):561–632
doi: 10.1093/eurheartj/ehab395
pubmed: 34453165
Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB (2002) Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106(24):3006–3008
doi: 10.1161/01.CIR.0000047200.36165.B8
pubmed: 12473543
Anwaruddin S, Desai Nimesh D, Vemulapalli S, Marquis-Gravel G, Li Z, Kosinski A, Michael JR (2021) Evaluating out-of-hospital 30-day mortality after transfemoral transcatheter aortic valve replacement. JACC 14(3):261–274
pubmed: 33541537
Fujita B, Schmidt T, Bleiziffer S, Bauer T, Beckmann A, Bekeredjian R, Möllmann H, Walther T, Landwehr S, Hamm C, Beyersdorf F, Katus HA, Harringer W, Ensminger S, Frerker C (2020) Impact of new pacemaker implantation following surgical and transcatheter aortic valve replacement on 1-year outcome. Eur J Cardiothorac Surg 57(1):151–159
doi: 10.1093/ejcts/ezz168
pubmed: 31199470
Mahajan S, Gupta R, Malik AH, Mahajan P, Aedma SK, Aronow WS, Mehta SS, Lakkireddy DR (2021) Predictors of permanent pacemaker insertion after TAVR: a systematic review and updated meta-analysis. J Cardiovasc Electrophysiol 32(5):1411–1420
doi: 10.1111/jce.14986
pubmed: 33682218
Barbanti M, Leipsic J, Binder R, Dvir D, Tan J, Freeman M, Norgaard B, Hansson N, Cheung A, Ye J, Yang TH, Maryniak K, Raju R, Thompson A, Blanke P, Lauck S, Wood D, Webb J (2014) Underexpansion and ad hoc post-dilation in selected patients undergoing balloon-expandable transcatheter aortic valve replacement. J Am Coll Cardiol 63(10):976–981
doi: 10.1016/j.jacc.2013.10.014
pubmed: 24211502
Moreno R, Dobarro D, López de Sá E, Prieto M, Morales C, Calvo Orbe L, Moreno-Gomez I, Filgueiras D, Sanchez-Recalde A, Galeote G, Jiménez-Valero S, Lopez-Sendon J-L (2009) Cause of complete atrioventricular block after percutaneous aortic valve implantation. Circulation 120(5):e29–e30
doi: 10.1161/CIRCULATIONAHA.109.849281
pubmed: 19652115
Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, Kapadia SR, Malaisrie SC, Cohen DJ, Pibarot P, Leipsic J, Hahn RT, Blanke P, Williams MR, McCabe JM, Brown DL, Babaliaros V, Goldman S, Szeto WY, Genereux P, Pershad A, Pocock SJ, Alu MC, Webb JG, Smith CR (2019) Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 380(18):1695–1705
doi: 10.1056/NEJMoa1814052
pubmed: 30883058
Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O’Hair D, Bajwa T, Heiser JC, Merhi W, Kleiman NS, Askew J, Sorajja P, Rovin J, Chetcuti SJ, Adams DH, Teirstein PS, Zorn GL, Forrest JK, Tchétché D, Resar J, Walton A, Piazza N, Ramlawi B, Robinson N, Petrossian G, Gleason TG, Oh JK, Boulware MJ, Qiao H, Mugglin AS, Reardon MJ (2019) Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med 380(18):1706–1715
doi: 10.1056/NEJMoa1816885
pubmed: 30883053
Petronio AS, Sinning J-M, Van Mieghem N, Zucchelli G, Nickenig G, Bekeredjian R, Bosmans J, Bedogni F, Branny M, Stangl K, Kovac J, Schiltgen M, Kraus S, de Jaegere P (2015) Optimal implantation depth and adherence to guidelines on permanent pacing to improve the results of transcatheter aortic valve replacement with the medtronic corevalve system: the corevalve prospective, international, post-market ADVANCE-II study. JACC 8(6):837–846
pubmed: 25999108
Franzoni I, Latib A, Maisano F, Costopoulos C, Testa L, Figini F, Giannini F, Basavarajaiah S, Mussardo M, Slavich M, Taramasso M, Cioni M, Longoni M, Ferrarello S, Radinovic A, Sala S, Ajello S, Sticchi A, Giglio M, Agricola E, Chieffo A, Montorfano M, Alfieri O, Colombo A (2013) Comparison of incidence and predictors of left bundle branch block after transcatheter aortic valve implantation using the Core Valve versus the Edwards valve. Am J Cardiol 112(4):554–559
doi: 10.1016/j.amjcard.2013.04.026
pubmed: 23726173
Guetta V, Goldenberg G, Segev A, Dvir D, Kornowski R, Finckelstein A, Hay I, Goldenberg I, Glikson M (2011) Predictors and course of high-degree atrioventricular block after transcatheter aortic valve implantation using the Core Valve revalving system. Am J Cardiol 108(11):1600–1605
doi: 10.1016/j.amjcard.2011.07.020
pubmed: 21880290
Ben-Shoshan J, Alosaimi H, Lauzier PT, Pighi M, Talmor-Barkan Y, Overtchouk P, Martucci G, Spaziano M, Finkelstein A, Gada H, Piazza N (2021) Double S-curve versus cusp-overlap technique: defining the optimal fluoroscopic projection for TAVR with a self-expanding device. JACC 14(2):185–194
pubmed: 33478635
Barthélémy O, Redheuil A, Collet J-P (2022) Cusp-overlapping projections in TAVR. JACC 15(2):162–164
pubmed: 35057986
Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62(10):1006–1012
doi: 10.1016/j.jclinepi.2009.06.005
pubmed: 19631508
Howick JC, Glasziou P, Greenhalgh, T; Thornton H (2011) The 2011 Oxford CEBM levels of evidence (introductory document). https://www.cebm.ox.ac.uk/resources/levels-of-evidence/ocebm-levels-of-evidence
Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR, Chan AW, Churchill R, Deeks JJ, Hróbjartsson A, Kirkham J, Jüni P, Loke YK, Pigott TD, Ramsay CR, Regidor D, Rothstein HR, Sandhu L, Santaguida PL, Schünemann HJ, Shea B, Shrier I, Tugwell P, Turner L, Valentine JC, Waddington H, Waters E, Wells GA, Whiting PF, Higgins JP (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919
doi: 10.1136/bmj.i4919
pubmed: 27733354
pmcid: 5062054
Mendiz OA, Noč M, Fava CM, Gutiérrez Jaikel LA, Sztejfman M, Pleskovič A, Gamboa P, Valdivieso LR, Gada H, Tang GHL (2021) Impact of cusp-overlap view for TAVR with self-expandable valves on 30-day conduction disturbances. J Interv Cardiol. https://doi.org/10.1155/2021/9991528
doi: 10.1155/2021/9991528
pubmed: 34007249
pmcid: 8099519
Pascual I, Almendárez M, Avanzas P, Álvarez R, Arboine LA, Del Valle R, Hernández-Vaquero D, Alfonso F, Morís C (2022) Cusp-overlapping TAVI technique with a self-expanding device optimizes implantation depth and reduces permanent pacemaker requirement. Rev Esp Cardiol (Engl Ed) 75(5):412–420
doi: 10.1016/j.recesp.2021.05.014
pubmed: 34226165
Pascual I, Hernández-Vaquero D, Alperi A, Almendarez M, Avanzas P, Kalavrouziotis D, Lorca R, Mesnier J, Arboine L, Mohammadi S, Valle RD, Dumont E, Leon V, De Larochelliere R, Rodés-Cabau J, Moris C (2022) Permanent pacemaker reduction using cusp-overlapping projection in TAVR: a propensity score analysis. JACC Cardiovasc Interv 15(2):150–161
doi: 10.1016/j.jcin.2021.10.002
pubmed: 35057985
Doldi PM, Stolz L, Escher F, Steffen J, Gmeiner J, Roden D, Linnemann M, Löw K, Deseive S, Stocker TJ, Orban M, Theiss H, Rizas K, Curta A, Sadoni S, Buech J, Joskowiak D, Peterss S, Hagl C, Massberg S, Hausleiter J, Braun D (2022) transcatheter aortic valve replacement with the self-expandable core valve evolut prosthesis using the cusp-overlap vs tricusp-view. J Clin Med. https://doi.org/10.3390/jcm11061561
doi: 10.3390/jcm11061561
pubmed: 35329887
pmcid: 8953752
Maier O, Piayda K, Binnebößel S, Berisha N, Afzal S, Polzin A, Klein K, Westenfeld R, Horn P, Jung C, Kelm M, Veulemans V, Zeus T (2022) Real-world experience with the cusp-overlap deployment technique in transcatheter aortic valve replacement: a propensity-matched analysis. Front Cardiovasc Med. https://doi.org/10.3389/fcvm.2022.847568
doi: 10.3389/fcvm.2022.847568
pubmed: 36684595
pmcid: 9471948
Auffret V, Puri R, Urena M, Chamandi C, Rodriguez-Gabella T, Philippon F, Rodés-Cabau J (2017) Conduction disturbances after transcatheter aortic valve replacement. Circulation 136(11):1049–1069
doi: 10.1161/CIRCULATIONAHA.117.028352
pubmed: 28893961
Sammour Y, Banerjee K, Kumar A, Lak H, Chawla S, Incognito C, Patel J, Kaur M, Abdelfattah O, Svensson LG, Tuzcu EM, Reed GW, Puri R, Yun J, Krishnaswamy A, Kapadia S (2021) Systematic approach to high implantation of SAPIEN-3 valve achieves a lower rate of conduction abnormalities including pacemaker implantation. Circulation 14(1):e009407
pubmed: 33430603
Regueiro A, Abdul-Jawad Altisent O, Del Trigo M, Campelo-Parada F, Puri R, Urena M, Philippon F, Rodés-Cabau J (2016) Impact of new-onset left bundle branch block and periprocedural permanent pacemaker implantation on clinical outcomes in patients undergoing transcatheter aortic valve replacement. Circulation 9(5):3635
Barbanti M, Costa G, Picci A, Criscione E, Reddavid C, Valvo R, Todaro D, Deste W, Condorelli A, Scalia M, Licciardello A, Politi G, De Luca G, Strazzieri O, Motta S, Garretto V, Veroux P, Giaquinta A, Giuffrida A, Sgroi C, Leon MB, Webb JG, Tamburino C (2020) Coronary cannulation after transcatheter aortic valve replacement: the RE-ACCESS study. JACC 13(21):2542–2555
pubmed: 33069648
Urena M, Webb JG, Tamburino C, Muñoz-García AJ, Cheema A, Dager AE, Serra V, Amat-Santos IJ, Barbanti M, Immè S, Briales JHA, Benitez LM, Al Lawati H, Cucalon AM, García-del-Blanco B, López J, Dumont E, De Larochellière R, Ribeiro HB, Nombela-Franco L, Philippon F, Rodés-Cabau J (2014) Permanent pacemaker implantation after transcatheter aortic valve implantation. Circulation 129(11):1233–1243
doi: 10.1161/CIRCULATIONAHA.113.005479
pubmed: 24370552
Kappetein AP, Head SJ, Généreux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodés-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB (2012) Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg 42(5):S45-60
doi: 10.1093/ejcts/ezs533
pubmed: 23026738